SlateStone Wealth’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,638
Closed -$246K 211
2022
Q4
$246K Buy
+2,638
New +$255K 0.06% 176
2020
Q3
Sell
-9,148
Closed -$595K 181
2020
Q2
$595K Buy
9,148
+830
+10% +$52.3K 0.13% 120
2020
Q1
$494K Buy
+8,318
New +$555K 0.14% 119
2019
Q2
Sell
-4,564
Closed -$246K 174
2019
Q1
$246K Sell
4,564
-380
-8% -$23.5K 0.08% 146
2018
Q4
$324K Buy
+4,944
New +$369K 0.15% 79

Other funds holding CVS

SlateStone Wealth's CVS Position: Q1 2023 in Review

SlateStone Wealth sold out of CVS Health (CVS) in Q1 2023, closing a stake of 2,638 shares — an estimated $246K sold.

SlateStone Wealth first reported a position in CVS in Q4 2018 and held it in 5 quarters. The position peaked at $595K in Q2 2020. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • SlateStone Wealth reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • SlateStone Wealth sold 2,638 CVS Health shares in Q1 2023, an estimated $246K.
  • SlateStone Wealth first reported a position in CVS Health in Q4 2018 and held it in 5 quarters.
  • SlateStone Wealth's CVS Health position peaked at $595K in Q2 2020.
  • 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on SlateStone Wealth's 13F filing for Q1 2023, filed 8 Aug 2023.